2017
DOI: 10.1016/j.cll.2017.07.008
|View full text |Cite
|
Sign up to set email alerts
|

Mast Cell Disease Assessment by Flow Cytometric Analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 27 publications
0
1
0
Order By: Relevance
“…Notably, MCs usually express CD9, CD25, CD33, CD44, and CD117 ( KIT ) . However a third of MCL cases reported in the literature had a double‐negative CD2/CD25 immunophenotype . In contrast to patients with ISM or ASM where neoplastic MCs express KIT D816V in a high proportion of cases, neoplastic MCs in MCL patients do not display the KIT D816V mutant in nearly 30%‐50% of the cases .…”
mentioning
confidence: 99%
“…Notably, MCs usually express CD9, CD25, CD33, CD44, and CD117 ( KIT ) . However a third of MCL cases reported in the literature had a double‐negative CD2/CD25 immunophenotype . In contrast to patients with ISM or ASM where neoplastic MCs express KIT D816V in a high proportion of cases, neoplastic MCs in MCL patients do not display the KIT D816V mutant in nearly 30%‐50% of the cases .…”
mentioning
confidence: 99%